HomeCompareBGPBF vs MRK

BGPBF vs MRK: Dividend Comparison 2026

BGPBF yields 2.72% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BGPBF wins by $1.63M in total portfolio value· pulled ahead in Year 2
10 years
BGPBF
BGPBF
● Live price
2.72%
Share price
$23.35
Annual div
$0.63
5Y div CAGR
69%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.69M
Annual income
$1,222,197.23
Full BGPBF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — BGPBF vs MRK

📍 BGPBF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBGPBFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BGPBF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BGPBF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BGPBF
Annual income on $10K today (after 15% tax)
$231.05/yr
After 10yr DRIP, annual income (after tax)
$1,038,867.65/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, BGPBF beats the other by $1,030,270.93/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BGPBF + MRK for your $10,000?

BGPBF: 50%MRK: 50%
100% MRK50/50100% BGPBF
Portfolio after 10yr
$872.7K
Annual income
$616,155.51/yr
Blended yield
70.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BGPBF
No analyst data
Altman Z
2.7
Piotroski
5/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BGPBF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBGPBFMRK
Forward yield2.72%2.81%
Annual dividend / share$0.63$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR69%32.7%
Portfolio after 10y$1.69M$57.7K
Annual income after 10y$1,222,197.23$10,113.78
Total dividends collected$1.62M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BGPBF vs MRK ($10,000, DRIP)

YearBGPBF PortfolioBGPBF Income/yrMRK PortfolioMRK Income/yrGap
1$11,159$459.38$11,213$373.04$54.00MRK
2← crossover$12,750$809.68$12,667$512.06+$83.00BGPBF
3$15,104$1,461.14$14,439$708.14+$665.00BGPBF
4$18,895$2,733.79$16,640$988.16+$2.3KBGPBF
5$25,619$5,401.63$19,432$1,394.07+$6.2KBGPBF
6$38,980$11,567.74$23,057$1,992.90+$15.9KBGPBF
7$69,508$27,799.11$27,889$2,894.79+$41.6KBGPBF
8$152,667$78,293.13$34,518$4,286.29+$118.1KBGPBF
9$434,957$271,603.94$43,912$6,494.35+$391.0KBGPBF
10$1,687,602$1,222,197.23$57,714$10,113.78+$1.63MBGPBF

BGPBF vs MRK: Complete Analysis 2026

BGPBFStock

BTS Group AB (publ) operates as a professional services firm. It operates through BTS North America, BTS Europe, BTS Other Markets, and APG segments. The company provides strategy execution and business transformation, leadership readiness and development, talent acquisition and succession, and go to market services. It also provides human-centric consulting services. BTS Group AB (publ) was founded in 1986 and is headquartered in Stockholm, Sweden.

Full BGPBF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BGPBF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BGPBF vs SCHDBGPBF vs JEPIBGPBF vs OBGPBF vs KOBGPBF vs MAINBGPBF vs JNJBGPBF vs ABBVBGPBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.